HCW Biologics Inc.
HCWB
$1.16
-$0.02-1.70%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 115.79% | -136.26% | 12.25% | 34.87% | 13.56% |
| Total Depreciation and Amortization | -9.78% | -40.42% | -30.33% | -38.61% | 431.54% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -385.84% | 184.54% | -476.29% | 45.70% | 25.69% |
| Change in Net Operating Assets | -69.49% | -374.22% | 97.92% | -395.55% | -170.94% |
| Cash from Operations | -3.57% | 1.29% | 6.59% | -23.95% | 3.13% |
| Capital Expenditure | -- | -- | -- | -- | -205.66% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -205.66% |
| Total Debt Issued | -- | -100.00% | -- | -- | -86.75% |
| Total Debt Repaid | -4.46% | -1.62% | 4.92% | -4.84% | -4.73% |
| Issuance of Common Stock | -62.75% | -62.38% | 311,500.00% | -99.96% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 5,614.17% | 92.09% | -3,499.10% | -100.96% | -- |
| Cash from Financing | 121.88% | -58.86% | 8,788.70% | -100.80% | 136.56% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 163.75% | -200.81% | 137.32% | -197.02% | 2,354.08% |